Replies to post #104118 on Kraig Biocraft Laboratories Inc (KBLB)

[TRUISM]

Since KBLB is nearing the end of the current finance agreement,

According to the SEC filing:

This prospectus relates to the resale of up to 110,000,000 shares of the common stock of Kraig Biocraft Laboratories, Inc., a Wyoming corporation, which shares will be offered and sold by the selling shareholder, Calm Seas Capital, LLC, a Nevada limited liability company (“Calm Seas”), pursuant to a “put right” under a letter agreement for an equity line financing, that we entered into with Calm Seas on October 2, 2014 (the “Letter Agreement”). The Letter Agreement permits us to “put” up to an aggregate of $7,500,000 in shares of our Class A common stock to Calm Seas during a two year period ending on the second anniversary of the effective date of the registration statement covering the resale of the put shares.

In the event that we raise substantially less than the maximum proceeds that we expect to raise under the equity line financing by the expiration of its 24 month term, we will seek to extend or renew the equity line financing with Calm Seas Capital to raise the short-fall additional revenue on substantially the same terms as under the Letter Agreement. If Calm Seas Capital is unwilling or unable to enter into such an arrangement, we will be forced to raise additional capital from other investors.

Notice of effectiveness date was 2015-06-05




Blessings to All

TRUTH

[Lebbe1]

Not sure if I agree with your assessment.
Not enough information to assess this.

If you look at decree 118/2015 it says:
When investing in Vietnam for the first time, foreign investors may choose to either register their investment projects before founding businesses in Vietnam or carry out both procedures simultaneously. It is worthy noting that under Decree No. 118, it takes only 15 days to fulfill procedures for grant of an investment registration certificate, given that the investment project does not require government approval and the investor satisfies all investment conditions,” Tuan said.

So it could take far less time for the subsidiary being started up.
Additionally, they made an agreement with a VN government, so IMO, they will make sure approvals will not take too much time, it's in their interest.

As for the crossbreeding:
We do not know if wnat to crossbreed all of their lines. Do they want to do it with MS? With DS? Maybe not....

Let's hope the Newsletter will give us a better idea...

[Cluck Kent]

Hi, Esk,
I just want to throw out a possibility that might have an effect on your conclusions and calculations, which would normally make sense, which is that, contrary to the amazing nature of the whole project, the 'mulberry' silkworms that are being used around the world to produce silk, including Vietnam, are easily commonly procurable, and so it's more than likely that Kraig has already started breeding and may be able to cut down on the time needed for cross breeding in Vietnam. With all the brilliant scientists they have working for them, I can't imagine they didn't already think of it, though I would be the first to admit I don't know. I've also stated in the past that it's my opinion that the Vietnamese 'cross breeding' is more necessary in order to give the Vietnamese a viable product, while not giving them the 'primary' transgenic source lines, which they can continue to leverage as time goes on. Also, considering that their real achievement here was creating gene 'stability' in the lines that they inserted genes in, and being primarily a technology company, it seems logical to ask what other purposes they can put that gene insertion tech to besides silkworms. In that case, spidersilk might be considered as just a way to create an income for the companies continued growth in the gene tech field. The implications of this for the stock are something I'm throwing out here as food for thought, and would taste better than 'mulberry leaves!' (sorry, couldn't resist the bad pun!)